Zoetis Inc. $ZTS Stock Position Boosted by Nordea Investment Management AB

Nordea Investment Management AB grew its stake in shares of Zoetis Inc. (NYSE:ZTS) by 16.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,753,209 shares of the company’s stock after buying an additional 397,043 shares during the quarter. Nordea Investment Management AB’s holdings in Zoetis were worth $396,985,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in ZTS. Halbert Hargrove Global Advisors LLC lifted its position in Zoetis by 496.6% in the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after purchasing an additional 144 shares during the period. REAP Financial Group LLC grew its holdings in Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after acquiring an additional 131 shares during the period. NewSquare Capital LLC raised its position in Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after acquiring an additional 85 shares in the last quarter. ORG Partners LLC raised its position in Zoetis by 56.8% in the second quarter. ORG Partners LLC now owns 232 shares of the company’s stock worth $37,000 after acquiring an additional 84 shares in the last quarter. Finally, Financial Consulate Inc. acquired a new stake in Zoetis in the 3rd quarter valued at about $39,000. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of Zoetis in a research note on Monday, December 29th. JPMorgan Chase & Co. reduced their target price on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. The Goldman Sachs Group raised shares of Zoetis to a “buy” rating in a research report on Monday, December 15th. Morgan Stanley set a $160.00 price target on shares of Zoetis in a research report on Thursday, December 18th. Finally, KeyCorp initiated coverage on shares of Zoetis in a research note on Thursday, November 20th. They issued a “sector weight” rating for the company. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $160.18.

Zoetis Stock Performance

Shares of ZTS stock opened at $125.31 on Tuesday. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.40. The stock’s 50-day moving average is $122.90 and its two-hundred day moving average is $140.26. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The firm has a market cap of $55.22 billion, a P/E ratio of 21.10, a PEG ratio of 2.59 and a beta of 0.97.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The firm’s revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, January 20th. This is a boost from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio (DPR) is presently 33.67%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.